TerrAscend (TSNDF) Cash from Financing Activities (2021 - 2026)

TerrAscend's (TSNDF) quarterly Cash from Financing Activities came in at -$7.1 million in Q1 2026, down 205.44% year-on-year from $6.8 million in Q1 2025, and down 22.63% on a QoQ basis from -$5.8 million in Q4 2025.

TerrAscend (TSNDF) Cash from Financing Activities (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Cash from Financing Activities data on file, last reported at -$7.1 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 205.44% year-over-year to -$7.1 million in Q1 2026; TTM through Mar 2026 was -$609000.0, a 96.51% increase from a year earlier, with the FY2025 full-year figure at $4.2 million, up 116.94% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$7.1 million, down from -$5.8 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for TSNDF reached as high as $17.1 million in Q1 2022 and fell as low as -$15.1 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged -$2.1 million across 5 years, with a median of -$4.4 million in 2024.
  • Across the five-year window, Cash from Financing Activities plunged 728.16% in 2023 and surged 283.0% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$1.8 million in 2022, then plunged by 728.16% to -$15.1 million in 2023, then soared by 70.78% to -$4.4 million in 2024, then tumbled by 32.18% to -$5.8 million in 2025, then fell by 22.63% to -$7.1 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$7.1 million in Q1 2026, -$5.8 million in Q4 2025, and $9.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn -7.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.13 Mn
Mar 31, 2026 -7.13 Mn
Dec 31, 2025 -5.82 Mn
Dec 31, 2025 -5.82 Mn
Sep 30, 2025 9.72 Mn
Sep 30, 2025 9.72 Mn
Jun 30, 2025 2.62 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 -2.34 Mn
Mar 31, 2025 -2.34 Mn
Dec 31, 2024 -4.40 Mn
Dec 31, 2024 -4.40 Mn
Sep 30, 2024 -5.31 Mn
Sep 30, 2024 -5.31 Mn
Jun 30, 2024 -5.41 Mn
Jun 30, 2024 -5.41 Mn
Mar 31, 2024 -9.60 Mn
Mar 31, 2024 -9.60 Mn
Dec 31, 2023 -15.06 Mn
Dec 31, 2023 -15.06 Mn